Skip to main content
logo
NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.02
-0.11 (-1.54%)
At close: Jul 8, 2026, 4:00 PM EDT
7.08
+0.06 (0.85%)
After-hours: Jul 8, 2026, 8:00 PM EDT

NeurAxis Revenue

NeurAxis had revenue of $1.61M in the quarter ending March 31, 2026, with 79.52% growth. This brings the company's revenue in the last twelve months to $4.28M, up 45.88% year-over-year. In the year 2025, NeurAxis had annual revenue of $3.57M with 32.89% growth.

Revenue (ttm)
$4.28M
Revenue Growth
+45.88%
P/S Ratio
20.48
Revenue / Employee
$178,396
Employees
24
Market Cap
86.94M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.57M883.35K32.89%
Dec 31, 20242.69M225.88K9.18%
Dec 31, 20232.46M-224.69K-8.37%
Dec 31, 20222.68M-36.55K-1.34%
Dec 31, 20212.72M791.06K40.98%
Dec 31, 20201.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Heron Therapeutics150.71M
Gossamer Bio55.54M
Pelthos Therapeutics27.70M
Seer, Inc.15.17M
Rallybio858.00K
Cardiff Oncology525.00K
iBio, Inc.300.00K
Revenue Rankings

NRXS News

More News